Academic Journal

pH-Responsive Alginate-Based Microparticles for Colon-Targeted Delivery of Pure Cyclosporine A Crystals to Treat Ulcerative Colitis

التفاصيل البيبلوغرافية
العنوان: pH-Responsive Alginate-Based Microparticles for Colon-Targeted Delivery of Pure Cyclosporine A Crystals to Treat Ulcerative Colitis
المؤلفون: Murtada A. Oshi, Juho Lee, Jihyun Kim, Nurhasni Hasan, Eunok Im, Yunjin Jung, Jin-Wook Yoo
المصدر: Pharmaceutics; Volume 13; Issue 9; Pages: 1412
بيانات النشر: Multidisciplinary Digital Publishing Institute
سنة النشر: 2021
المجموعة: MDPI Open Access Publishing
مصطلحات موضوعية: cyclosporine A, colon-targeted delivery, ionic gelation, microparticles, ulcerative colitis
الوصف: Cyclosporine A (CsA) is a potent immunosuppressant for treating ulcerative colitis (UC). However, owing to severe systemic side effects, CsA application in UC therapy remains limited. Herein, a colon-targeted drug delivery system consisting of CsA crystals (CsAc)-loaded, Eudragit S 100 (ES)-coated alginate microparticles (CsAc-EAMPs) was established to minimize systemic side effects and enhance the therapeutic efficacy of CsA. Homogeneously-sized CsAs (3.1 ± 0.9 μm) were prepared by anti-solvent precipitation, followed by the fabrication of 47.1 ± 6.5 μm-sized CsAc-EAMPs via ionic gelation and ES coating. CsAc-EAMPs exhibited a high drug loading capacity (48 ± 5%) and a CsA encapsulation efficacy of 77 ± 9%. The in vitro drug release study revealed that CsA release from CsAc-EAMPs was suppressed under conditions simulating the stomach and small intestine, resulting in minimized systemic absorption and side effects. Following exposure to the simulated colon conditions, along with ES dissolution and disintegration of alginate microparticles, CsA was released from CsAc-EAMPs, exhibiting a sustained-release profile for up to 24 h after administration. Given the effective colonic delivery of CsA molecules, CsAc-EAMPs conferred enhanced anti-inflammatory activity in mouse model of dextran sulfate sodium (DSS)-induced colitis. These findings suggest that CsAc-EAMPs is a promising drug delivery system for treating UC.
نوع الوثيقة: text
وصف الملف: application/pdf
اللغة: English
Relation: Biopharmaceutics; https://dx.doi.org/10.3390/pharmaceutics13091412
DOI: 10.3390/pharmaceutics13091412
الاتاحة: https://doi.org/10.3390/pharmaceutics13091412
Rights: https://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.AA9157FC
قاعدة البيانات: BASE
الوصف
DOI:10.3390/pharmaceutics13091412